1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Demographic features of patients and controls
Control FTD SD PNFA AD No. 27 12 13 9 19 Sex (M:F) 7:20 3:10 5:9 3:6 7:12 Age (yr) 61.1 (53–78) 59.45 (42–72) 63.77 (52–77) 64.9 (57–78) 61.8 (56–75) MMSE 28.7 (25–30) 20.83 (10–30)* 22.92 (5–29)* 22.5 (15–28)† 23.1 (7–29)* Disease duration (yr) – 1.65 (0,25–3,4) 3.90 (1,3–7,7)‡ 3.56 (0,06–8,13) 2.87 (0–4,97)
Note:—FTD indicates frontotemporal dementia; SD, semantic dementia; PNFA, progressive nonfluent aphasia; AD, Alzheimer disease; MMSE, MIni-Mental State Examination.
*,†,‡ Kruskal-Wallis test.
* P < .01 compared with controls.
† P < .05 compared with controls.
‡ P < 01 compared with FTD.